High Levels of Complement Activating Enzyme MASP-2 Are Associated With the Risk of Future Incident Venous Thromboembolism.

Christabel Esi Damoah Omri SnirKristian HindbergPeter GarredJudith K LudviksenSigrid K BrækkanVânia M MorelliTom Eirik MollnesJohn-Bjarne Hansennull null

Published in: Arteriosclerosis, thrombosis, and vascular biology (2022)

Our findings suggest that high plasma MASP-2 levels are causally associated with risk of future VTE.

Keyphrases

venous thromboembolism
current status
direct oral anticoagulants
cardiovascular disease
signaling pathway
atrial fibrillation